Regeneron Pharmaceuticals, Inc.

Swiss National Bank REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

285,460

Value ($000)

220,338

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	220,338	0.1%	285,460	12/31/2025
2025 Q3	11/13/2025	172,055	0.1%	306,000	9/30/2025
2025 Q2	8/12/2025	169,943	0.1%	323,700	6/30/2025
2025 Q1	5/12/2025	193,313	0.1%	304,800	3/31/2025
2024 Q4	2/10/2025	218,187	0.1%	306,300	12/31/2024
2024 Q3	11/7/2024	338,079	0.2%	321,600	9/30/2024
2024 Q2	8/8/2024	335,909	0.2%	319,600	6/30/2024
2024 Q1	5/7/2024	308,767	0.2%	320,800	3/31/2024
2023 Q4	2/6/2024	293,173	0.2%	333,800	12/31/2023
2023 Q3	11/8/2023	285,649	0.2%	347,100	9/30/2023
2023 Q2	8/9/2023	279,009	0.2%	388,300	6/30/2023
2023 Q1	5/10/2023	349,210	0.2%	425,000	3/31/2023
2022 Q4	2/8/2023	314,281	0.2%	435,600	12/31/2022
2022 Q3	11/9/2022	322,510	0.2%	468,172	9/30/2022
2022 Q2	8/9/2022	273,618	0.2%	462,872	6/30/2022
2022 Q1	5/9/2022	319,787	0.2%	457,872	3/31/2022
2021 Q4	2/8/2022	252,275	0.2%	399,472	12/31/2021
2021 Q3	11/8/2021	250,528	0.2%	413,972	9/30/2021
2021 Q2	8/6/2021	239,821	0.1%	429,372	6/30/2021
2021 Q1	5/7/2021	287,112	0.2%	606,822	3/31/2021
2020 Q4	2/5/2021	287,992	0.2%	596,122	12/31/2020
2020 Q3	11/9/2020	319,143	0.2%	570,122	9/30/2020
2020 Q2	8/5/2020	299,116	0.3%	479,622	6/30/2020
2020 Q1	5/8/2020	153,431	0.2%	314,222	3/31/2020
2019 Q4	2/6/2020	95,906	0.1%	255,422	12/31/2019
2014 Q2	8/6/2014	21,552	0.1%	76,300	6/30/2014
2014 Q1	5/6/2014	22,671	0.1%	75,500	3/31/2014
2013 Q4	1/31/2014	22,680	0.1%	82,400	12/31/2013